Improved Screening for Osteoporosis

Osteoporosis Clinical Trial

— ADOV  

Official title:

Improved Screening for Osteoporosis in Women Between 50 and 80 Years Hospitalized in Hospital Departmental Vendee

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02066480
• Other study ID #: CHD 086-13
• Status: Completed
• Phase: N/A
• First received: February 17, 2014
• Last updated: May 18, 2015
• Start date: March 2014
• Est. completion date: May 2015

Study information

• Verified date: December 2014
• Source: Centre Hospitalier Departemental Vendee
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: The Commission nationale de l’informatique et des libertés
• Study type: Observational

Clinical Trial Summary

Osteoporosis is a disease characterized by skeletal fragility due to decreased bone mass and deterioration of bone microarchitecture , leading to increased fracture risk for low trauma, such as spinal fractures or femoral neck .

It is estimated that 3 million people are living in France , particularly women , with an incidence that increases with age .

This disease is a major public health issue in terms of morbidity and mortality , costs and risk of recurrence (after a first fracture episode) , including risk factors are identified.

However, although bone densitometry is a reliable diagnostic tool and preventive treatments are at our disposal, screening for osteoporosis is still insufficient .

The objective of our study is to improve the detection of osteoporosis in Hospital Departmental Vendee , using a simple questionnaire seeking risk factors followed by bone densitometry or if risk factors are found. Based on the results , the patient will be sent in rheumatology consultation for implementation of treatment if necessary .

Therefore included women hospitalized in medical services , gynecology, surgery and orthopedics Hospital Departmental Vendee , aged 50 to 80 years. Will not be included women who could answer a simple questionnaire and those previously treated for osteoporosis or have already received a bone density there is less than 3 years old .

Recruitment information / eligibility

• Status: Completed
• Enrollment: 3226
• Est. completion date: May 2015
• Est. primary completion date: March 2015
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 50 Years to 80 Years

Eligibility

Inclusion Criteria:

• Women between 50 and 80 years

• Hospitalized

• In health services, orthopedics, gynecology, surgery

• Able to respond to an easy questionnaire

• Able to give their agreement to participate in the study

Exclusion Criteria:

• Patients with dementia

• Patients can not express

• Patients at end of life

• Patients previously treated for osteoporosis or recent densitometry (BMD) <3 years

• Patients could not be seen in time by the nurse during their hospitalization

• Patients receiving a measure of legal protection

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Osteoporosis

Locations

Country	Name	City	State
France	Centre hospitalier départemental Vendée	La Roche sur Yon

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Departemental Vendee

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of patients screened at risk for osteoporosis		1 year	No